Amita Oza, MD
Internal Medicine · Dayton, OHNPI 1285634865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 441 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AstraZeneca at 26.4% of the total. Reporting peaked in 2023 at $2,222 and has fallen 95.9% since, to $91 in 2024. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 441 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- AbbVie$2K
- Lilly USA, LLC$813
- Johnson & Johnson$808
- Pfizer$702
- Novo Nordisk$682
- plus $2K from 24 others
Across 125 payments — averaging $1486.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$181K
- Shionogi Inc$5K
What the payments were for
- Food & beverage$9,605100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 107 | $2,538 |
| AbbVie(2 entities) | 90 | $1,789 |
| Lilly USA, LLC | 38 | $813 |
| Johnson & Johnson | 40 | $808 |
| Pfizer | 47 | $702 |
| Novo Nordisk | 35 | $682 |
| Bayer | 17 | $389 |
| GSK | 9 | $355 |
| Teva Pharmaceuticals USA, Inc. | 6 | $331 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $145 |
| Astellas Pharma US Inc | 1 | $129 |
| Abbott | 6 | $108 |
| Boehringer Ingelheim | 7 | $107 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $92 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $72 |
| Mylan Specialty L.p. | 1 | $64 |
| Esperion Therapeutics, Inc. | 1 | $62 |
| Biohaven Pharmaceuticals, Inc. | 2 | $53 |
| Orexo US, Inc. | 4 | $49 |
| Merck | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Alkermes, Inc. | 1 | $29 |
| Novartis | 1 | $21 |
| Exact Sciences | 1 | $18 |
| Renalytix AI, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Amgen | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Circassia Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,605 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 16 | $38 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Dayton
- Richard KimDayton$326K
- Isaac HumphreyDayton$224K
- Celine JacobDayton$126K
- Miguel PariloDayton$84K
- Richard SaxenDayton$38K
- Mamle AnimDayton$37K
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.